Glucocorticoid receptor drugs for Chronic Obstructive Pulmonary Disease

2 tracked Glucocorticoid receptor drugs in the Chronic Obstructive Pulmonary Disease race. The class explanation lives on the Glucocorticoid receptor page; the full indication pipeline across every mechanism is on the Chronic Obstructive Pulmonary Disease page.

2 approved / phase 4

Head-to-head evidence: fluticasone furoate/umeclidinium/vilanterol vs fluticasone furoate/vilanterol

The roster

← all Glucocorticoid receptor drugs